Vericel is a specialty biopharmaceutical company focused on advanced therapies for severe medical conditions in sports medicine and burn care. Its commercial portfolio includes cell-therapy and biologic products such as MACI, Epicel, and NexoBrid.
Core Offerings
- Cell therapy products for cartilage repair and severe burn treatment
- Specialty biologic products for burn-eschar removal
- Clinical and medical support for treatment centers and provider teams
Capabilities
- Manufacturing and quality systems for advanced therapy products
- Regulatory and commercial execution in high-specialty care settings
- Focused provider support across burn centers and orthopedic specialists
Commercial Model
Vericel primarily serves hospitals, surgery centers, and specialist providers through a B2B commercialization model centered on high-value specialty therapeutics.